声明:本材料疾病教育部分内容仅供参考,不用于任何推广目的。如有疑问请咨询医疗卫生专业人士。
审批编号:CN-144853 过期日期:2025-11-12
封面图片来源：觅健的版权图库
责任编辑：觅健零零
本文作者：觅健一一
参考文献：
[1] Derwahl M, Nicula D. Estrogen and its role in thyroid cancer[J]. Endocr Relat Cancer, 2014, 21(5): T273-T283. DOI:10.1530/ERC-14-0053
[2] Freddie Bray, et al.Global cancer statistics 2022 : GLOBO CA Nestimates of incidence and mortality world wide for 36 cancers in 185 countrie. DOI: 10.3322/caac.21834
[3]Del Pup L, Mantovani A, Cavaliere C, et al．Carcinogenetic mechanisms of endocrine disruptors in female cancers( Ｒeview) [J]．Oncol Ｒep, 2016, 36(2) : 603-612．
[4] Li ST, Yang J, Shen YW, et al. Clinicopathological features, survival and risk in breast cancer survivors with thyroid cancer: an analysis of the SEER database[J]. BMC Public Health, 2019, 19(1): 1592. DOI:10.1186/s12889-019-7947-y
[5] Ikeda Y, Kiyotani K, Yew PY, et al. Germline PARP4 mutations in patients with primary thyroid and breast cancers[J]. Endocr Relat Cancer, 2016, 23(3): 171-179.
[6] Gupte R, Liu ZY, Kraus WL. PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes[J]. Genes Dev, 2017, 31(2): 101-126. DOI:10.1101/gad.291518.116
[7] 优甲乐药品说明书
